Phillip Noe - Cross Country Chief Officer
| CCRN Stock | USD 17.26 0.03 0.17% |
Insider
Phillip Noe is Chief Officer of Cross Country Healthcare
| Age | 53 |
| Address | 6551 Park of Commerce Boulevard, N.W., Boca Raton, FL, United States, 33487 |
| Phone | 561 998 2232 |
| Web | https://www.crosscountry.com |
Phillip Noe Latest Insider Activity
Tracking and analyzing the buying and selling activities of Phillip Noe against Cross Country stock is an integral part of due diligence when investing in Cross Country. Phillip Noe insider activity provides valuable insight into whether Cross Country is net buyers or sellers over its current business cycle. Note, Cross Country insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cross Country'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Phillip Noe over six months ago Disposition of 956 shares by Phillip Noe of Cross Country at 14.93 subject to Rule 16b-3 |
Cross Country Management Efficiency
The company has return on total asset (ROA) of 0.0127 % which means that it generated a profit of $0.0127 on every $100 spent on assets. This is way below average. Cross Country's management efficiency ratios could be used to measure how well Cross Country manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cross Country's Return On Tangible Assets are very stable compared to the past year. As of the 27th of February 2025, Return On Capital Employed is likely to grow to 0.20, while Return On Equity is likely to drop 0.14. At this time, Cross Country's Return On Assets are very stable compared to the past year.Similar Executives
| Showing other executives | INSIDER Age | ||
| Joseph Dyer | ASGN Inc | 73 | |
| Julie Fletcher | AMN Healthcare Services | N/A | |
| Carolyn Kenny | AMN Healthcare Services | N/A | |
| Adam Bleibtreu | ASGN Inc | N/A | |
| Carol Lindstrom | ASGN Inc | 66 | |
| Peter Boland | Kelly Services A | 59 | |
| Michael Payne | ASGN Inc | 66 | |
| Jorge Caballero | AMN Healthcare Services | 64 | |
| Christopher Schwartz | AMN Healthcare Services | N/A | |
| Robin Palmer | ASGN Inc | N/A | |
| Janis Acosta | Kelly Services A | 54 | |
| R Harris | AMN Healthcare Services | 66 | |
| Jon Balousek | Central Garden Pet | 55 | |
| Timothy Cofer | Central Garden Pet | 55 | |
| Denis Edwards | Kforce Inc | N/A | |
| Michele McCauley | ASGN Inc | N/A | |
| Maria Hawthorne | ASGN Inc | 61 | |
| Teri Fontenot | AMN Healthcare Services | 67 | |
| Sylvia TrentAdams | AMN Healthcare Services | 55 | |
| Mike McGoohan | Central Garden Pet | N/A | |
Management Performance
| Return On Equity | -0.004 | ||||
| Return On Asset | 0.0127 |
Cross Country Healthcare Leadership Team
Elected by the shareholders, the Cross Country's board of directors comprises two types of representatives: Cross Country inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cross. The board's role is to monitor Cross Country's management team and ensure that shareholders' interests are well served. Cross Country's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cross Country's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen VargaSinka, Director Communications | ||
| Joshua Vogel, Vice Relations | ||
| Colin MS, Chief Officer | ||
| BA MDiv, Senior Officer | ||
| John Martins, CEO President | ||
| MBA JD, Group Delivery | ||
| Daniel White, Chief Officer | ||
| III CPA, Senior Officer | ||
| RN BSN, Chief Solutions | ||
| JD MBA, Executive Officer | ||
| James III, VP Officer | ||
| Gerald Purgay, Chief Officer | ||
| Mark Fortunato, Vice Development | ||
| MBA RN, Exec Officer | ||
| Kevin Clark, President CEO, Director | ||
| Phillip Noe, Chief Officer |
Cross Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cross Country a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.004 | ||||
| Return On Asset | 0.0127 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 497.17 M | ||||
| Shares Outstanding | 32.28 M | ||||
| Shares Owned By Insiders | 5.50 % | ||||
| Shares Owned By Institutions | 98.83 % | ||||
| Number Of Shares Shorted | 2.32 M | ||||
| Price To Earning | 5.59 X |
Pair Trading with Cross Country
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.Moving against Cross Stock
| 0.73 | TFX | Teleflex Incorporated | PairCorr |
| 0.72 | UHS | Universal Health Services | PairCorr |
| 0.71 | CI | Cigna Corp | PairCorr |
| 0.63 | NHC | National HealthCare | PairCorr |
| 0.6 | SEM | Select Medical Holdings | PairCorr |
The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.
The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth (0.29) | Return On Assets |
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.